May-Thurner Syndrome

The American Journal of the Medical Sciences
Yub Raj SedhaiPriyanka T Bhatacharya

Abstract

This single-center, retrospective review identified 6 patients (n = 6, 100% female) treated by endovascular therapy for May-Thurner syndrome from June 2013 to September 2015. Patients consisted of 3 African American, 2 Caucasian and 1 Asian; mean age was 53.50 ± 8.31 years, range: 39-63 years. Clinical presentations consisted of left lower extremity deep vein thrombosis in 4, left lower extremity deep vein thrombosis with pulmonary embolism in 1 and pulmonary embolism with left common iliac vein thrombosis in 1 patient. All 6 patients were treated with catheter-directed thrombolysis and venous stenting to correct the underlying anatomical defect. Hypercoagulability work up revealed antiphospholipid antibody syndrome in 1 patient. No major periprocedural complications were observed. Median follow-up period was 22 ± 5.5 months (range: 13-30 months). One patient with pre-exiting antiphospholipid antibody syndrome developed stent thrombosis with secondary loss of patency. Endovascular therapy for May-Thurner syndrome in our adult cohort seemed safe and effective. One patient with pre-existing thrombophilia developed secondary loss of stent patency, suggesting need for further investigation in this subgroup.

Citations

Mar 26, 2019·Journal of the American Association of Nurse Practitioners·Jennifer Ruel
Jul 7, 2019·BMJ Case Reports·Kay Tai Choy, Sherab Bhutia
Apr 3, 2020·Angiologii︠a︡ i sosudistai︠a︡ khirurgii︠a︡ = Angiology and vascular surgery·I M Ignat'evM Iu Volodiukhin
Mar 24, 2021·Journal De Médecine Vasculaire·M C MontesJ E Gómez-Mesa
Apr 1, 2021·Curēus·Kishore KarriPradeep Yarra
Apr 4, 2021·Medicina clínica·Alejandra García-GarcíaPablo Demelo-Rodríguez
Sep 1, 2021·Curēus·Wasey Ali Yadullahi MirLarissa Verda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.